OIP5 and bipolar disorder: Along with the assessment of the expression of CCAT2, TUG1 and PANDA transcription levels, OIP5‐AS1 helped to improve the sensitivity and specificity for bipolar disorder diagnosis to 96%, and is thus a potential biomarker.